| | Index diagnosis |
|---|
Variables | All ALD-related costs1
| Decompensated cirrhosis | Hepatocellular carcinoma |
P-value2
|
|---|
N | 1193 | 1098 | 73 | |
Inpatient | | | | |
Mean (SD) | $1,272 ($2,926) | $1,242 ($2,806) | $2,093 ($4,539) | 0.624 |
Median | $0 | $0 | $0 | |
IQR | $0-$1,006 | $0-$1,056 | $0-$1,155 | |
Outpatient | | | | |
Mean (SD) | $83 ($184) | $76 ($168) | $202 ($341) | 0.051 |
Median | $23 | $23 | $37 | |
IQR | $6-$79 | $7-$78 | $8-$157 | |
Other costs3
| | | | |
Mean (SD) | $1 ($11) | $1 ($11) | $2 ($10) | <.001 |
Median | $0 | $0 | $0 | |
IQR | $0-$0 | $0-$0 | $0-$0 | |
Total costs4
| | | | |
Mean (SD) | $1,356 ($2,981) | $1,319 ($2,848) | $2,297 ($4,700) | 0.807 |
Median | $88 | $96 | $67 | |
- Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
- Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.
-
1 “ALD-Related Costs” includes all patients with HCV and ALD, including 22 patients whose index ALD diagnosis was a transplant procedure or history of transplant.
-
2 Calculated with the Wilcoxon test for comparison of means.
-
3 "Other" costs include nursing home, home health, hospice, and other services.
-
4 "Total costs" include inpatient, outpatient, pharmacy, and other (nursing home, home health, hospice, and other services) costs. Pharmacy and other costs comprised < $5 of mean total ALD-related costs in each cohort.
-
ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.
